Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders

Eleven piperazine-containing 1,3-diphenylprop-2-en-1-one derivatives (PC1-PC11) were evaluated for their inhibitory activities against monoamine oxidases (MAOs), cholinesterases (ChEs), and β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) with a view toward developing new treatments for n...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Bijo, Oh, Jong Min, Baty, Roua S., Batiha, Gaber El-Saber, Parambi, Della Grace Thomas, Gambacorta, Nicola, Nicolotti, Orazio, Kim, Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980107/
https://www.ncbi.nlm.nih.gov/pubmed/33743158
http://dx.doi.org/10.1007/s11356-021-13320-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980107/
https://www.ncbi.nlm.nih.gov/pubmed/33743158
http://dx.doi.org/10.1007/s11356-021-13320-y

Ejemplares similares